Wealth Effects LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, HoldingsChannel reports. The fund purchased 14,490 shares of the company’s stock, valued at approximately $6,999,000. Astera Labs makes up approximately 1.9% of Wealth Effects LLC’s holdings, making the stock its 11th biggest position.
A number of other institutional investors have also modified their holdings of ALAB. Atreides Management LP boosted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Amundi grew its stake in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership acquired a new position in Astera Labs in the 4th quarter valued at $148,980,000. Goldman Sachs Group Inc. raised its holdings in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after acquiring an additional 858,693 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.
Insiders Place Their Bets
In related news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total transaction of $3,276,963.90. Following the completion of the transaction, the director owned 5,292 shares in the company, valued at $1,928,140.20. The trade was a 62.96% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 940,716 shares of company stock worth $292,425,777. 10.40% of the stock is owned by insiders.
Analyst Ratings Changes
Get Our Latest Analysis on ALAB
Astera Labs Stock Performance
Shares of ALAB opened at $321.61 on Monday. The firm has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. The stock’s fifty day simple moving average is $358.00 and its 200 day simple moving average is $240.74. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
